Item 5.07 Submission of Matters to a Vote of Security Holders.
On June 8, 2023, Revolution Medicines, Inc. held its 2023 annual
meeting of stockholders . At the Annual Meeting, the
Company s. | June 9, 2023
SVB Securities downgraded shares of Blueprint Medicines (NASDAQ:BPMC – Get Rating) from a market perform rating to an underperform rating in a research note issued to investors on Monday morning, The Fly reports. They currently have $43.00 target price on the biotechnology company’s stock, down from their prior target price of $48.00. Other analysts have […]
Blueprint Medicines Co. (NASDAQ:BPMC – Get Rating) insider Percy H. Carter sold 2,307 shares of the stock in a transaction that occurred on Monday, June 5th. The shares were sold at an average price of $52.06, for a total value of $120,102.42. Following the transaction, the insider now directly owns 38,117 shares of the company’s […]
SVB Leerink lowered shares of Blueprint Medicines (NASDAQ:BPMC – Get Rating) from a market perform rating to an underperform rating in a report published on Monday, PriceTargets.com reports. A number of other research firms also recently weighed in on BPMC. Raymond James dropped their target price on Blueprint Medicines from $115.00 to $85.00 and set […]
Blueprint Medicines Co. (NASDAQ:BPMC – Get Rating) shares traded down 5.9% on Thursday following insider selling activity. The stock traded as low as $56.44 and last traded at $56.48. 317,027 shares changed hands during mid-day trading, a decline of 45% from the average session volume of 581,232 shares. The stock had previously closed at $60.03. […]